Your session is about to expire
← Back to Search
DCE-MRI and DWI for Detection and Diagnosis of Breast Cancer (ACRIN6702 Trial)
N/A
Waitlist Available
Led By Savannah Partridge, PhD
Research Sponsored by American College of Radiology Imaging Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a special MRI scan to see if it can better identify cancerous lumps in women with suspicious breast areas. The scan looks at how water moves in the tissue to tell if a lump is likely cancer or not. This noninvasive technique has shown promise in differentiating between benign and malignant breast lesions.
Eligible Conditions
- Breast Cancer
- Breast Imaging Reporting and Data System (BI-RADS)
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Apparent Diffusion Coefficient (ADC)
Secondary study objectives
ADC Measurements/Ratios to Define Subject Lesion Variations
Combination Variables (ADC Nonzero Minimum B-Value and/or Normalized ADC)
Local and Central Review Comparison (ADC Value Differences)
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: DCE-MRI and DWIExperimental Treatment1 Intervention
Single arm study, diagnosis defined as BIRADS 3, 4, or 5 lesion(s) based on DCE-MRI only with DWI collected in tandem as standard practice.
Find a Location
Who is running the clinical trial?
American College of Radiology Imaging NetworkLead Sponsor
39 Previous Clinical Trials
465,860 Total Patients Enrolled
7 Trials studying Breast Cancer
51,357 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,938 Previous Clinical Trials
41,023,070 Total Patients Enrolled
942 Trials studying Breast Cancer
1,443,157 Patients Enrolled for Breast Cancer
Eastern Cooperative Oncology GroupNETWORK
268 Previous Clinical Trials
151,495 Total Patients Enrolled
30 Trials studying Breast Cancer
45,987 Patients Enrolled for Breast Cancer
Habib Rahbar, MDStudy ChairUniversity of Washington
Savannah Partridge, PhDPrincipal InvestigatorUniversity of Washington
Thomas Chenevert, PhDStudy ChairUniversity of Michigan